1. New drug targets for lethal brain cancer discovered
More than 200 genes with novel and known roles in glioblastoma—the most aggressive type of brain cancer—offer promising new drug targets. more details...


2. Integra LifeSciences Receives FDA Clearance for Specific Neurosurgery Indication for CUSA® Clarity
First and Only Ultrasonic Tissue Ablation System Cleared to Treat Malignant and Benign Tumors, but Not Limited to Meningiomas and Gliomas more details...


3. HER2+ Breast Cancer With Brain Metastases: Unmet Needs Remain
Patients with metastatic HER2-positive breast cancer who later develop central nervous system (CNS) metastases comprise a large population of all patients with breast cancer, and there continue to be an unmet need for this subgroup, explained Brian Czerniecki, MD, PhD. more details...


4. FDA Approves New Indication for Drug Containing an Active Ingredient Derived from Cannabis to Treat Seizures in Rare Genetic Disease
Today, the U.S. Food and Drug Administration approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with tuberous sclerosis complex (TSC) in patients one year of age and older. more details...


1. ‘PAZitive’ Living With a Brain Cancer Diagnosis
When Karen Botnick Paz had an MRI, she never imagined the scan would reveal a cancerous brain tumor. Following a brain biopsy, the pathology showed there was a good chance the tumor would respond favorably to chemotherapy, due to certain genetic markers. more details...